跳至主要内容
临床试验/NCT03765684
NCT03765684进行中(未招募)不适用

Effects of Various Parental and Gestational Factors on Offspring Body Composition and Health in Later Life in Helsinki Birth Cohort 2018-2022

Helsinki University Central Hospital1 个研究点 分布在 1 个国家目标入组 1,000 人开始时间: 2018年12月1日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
1,000
试验地点
1
主要终点
Neonatal body fat %

研究概览

简要总结

In Helsinki Birth Cohort 2018-2022 a large, longitudinal and well-phenotyped birth cohort of infants and their parents will be established. Mothers, fathers/spouses and their children in Helsinki and Uusimaa Hospital District are recruited in the study and newborn composition of the children born in Helsinki Women's Hospital will be measured. Data on maternal and paternal diet quality, physical activity and depression during and after pregnancy will be collected and data from the hospital and national registers will be collected. Health of offspring and parents will be followed during their later life.

详细描述

Helsinki Birth Cohort 2018-2022 (HeBiCo) study is designed to find evidence between various intrauterine exposures and offspring adiposity and later health. It will be examined how different maternal (e.g. chronic diseases, ethnicity, BMI), and obstetric factors (e.g. gestational weight gain, diagnoses during pregnancy) as well as parental lifestyle and psychological aspects (e.g. diet quality, physical activity, depression and anxiety) are associated with newborn body composition and later health (e.g. obesity and neurocognitive health).

In the first phase of the study the participants are recruited on postnatal ward after delivery. The umbilical cord blood sample will be collected of all the neonates. After a consent the participants fill in the digital background, food frequency, depression and physical activity questionnaires. If the parents do not give their consent, the umbilical cord blood sample will be destroyed. Body composition of offspring will be assessed within 72 hours after birth. Registry data will be collected.

The second phase of the HeBiCo study is based on the HUS WomensHub treatment path and/or Apotti platform. The second phase of the HeBiCo constitutes of the mother-child pairs (and fathers/spouses) whose pregnancy can be followed from the early pregnancy to the end of the pregnancy through treatment path. Body composition of offspring born in Helsinki Women's Hospital will be assessed within 72 hours after birth.

The future studies will include 1) the intervention studies with digital service concept through WomensHub platform, and 2) the follow-up studies of offspring and parents in later life (to establish e.g. growth trajectories and later metabolic health of offspring).

The first phase of the HeBiCo study was registered 3/2018.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Mothers, fathers/spouses and offspring in Helsinki and Uusimaa Hospital District.

排除标准

  • Inability to communicate in Finnish language

结局指标

主要结局

Neonatal body fat %

时间窗: Within 72 hours of birth

Measured with PEA POD Cosmed® Infant Body Composition Assessment system

次要结局

  • ASQ-3(3 months, 1 year and 2 years of age)
  • Newborn height(Within 2 hours of birth)
  • Newborn weight(Within 2 hours of birth)
  • ITSEA(3 months, 1 year and 2 years of age)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Saila Koivusalo

Associate Professor, Development Manager

Helsinki University Central Hospital

研究点 (1)

Loading locations...

相似试验

Factors Affecting Newborn Body Composition and Later... | 临床试验